Anand, Inder S <br/><br/>
Serial measurement of growth-differentiation factor-15 in heart failure: relation to disease severity and prognosis in the Valsartan Heart Failure Trial.  [electronic resource] 

 -  Circulation  Oct 2010 
 - 1387-95 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/CIRCULATIONAHA.109.928846  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Angiotensin II Type 1 Receptor Blockers--therapeutic use<br/>Atrial Fibrillation--complications<br/>Biomarkers--blood<br/>Diabetic Angiopathies--epidemiology<br/>Female<br/>Growth Differentiation Factor 15--blood<br/>Heart Failure--blood<br/>Humans<br/>Hypertension--complications<br/>Male<br/>Middle Aged<br/>Placebos<br/>Prognosis<br/>Regression Analysis<br/>Risk Assessment<br/>Risk Factors<br/>Severity of Illness Index<br/>Tetrazoles--therapeutic use<br/>Valine--analogs & derivatives<br/>Valsartan